Who it affects

• Historically most common in adults aged 30‑60 years.
• Higher prevalence in men than women (approximately 2–3 : 1).
• Geographically more frequent in arid, hot climates (e.g., parts of the Middle East, South Asia, and some U.S. Southwest regions).

Prevalence

• Exact global prevalence is unknown because many cases are misdiagnosed, but estimates range from 0.5 % to 2 % of the adult population in endemic areas.¹
• In the United States, primary atrophic rhinitis accounts for less than 1 % of all otolaryngology referrals.²

Symptoms

The symptom profile can be insidious, often developing over months to years. Common features include:

Nasality and Discharge

• Foul‑smelling (fetid) crusts – usually brown‑black or gray, may become hard and adherent.
• Persistent nasal discharge – watery to mucoid, often worsening in dry environments.
• Halitosis (bad breath) secondary to dried secretions.

Structural Changes

• Enlarged, widened nostrils (nares) due to loss of mucosal support.
• Thinning of nasal mucosa – appears pale, dry, and can be visualized on endoscopy.
• Loss of nasal hairs (cilia) – reduces the nose’s natural filtration.

Sensory & Functional Issues

• Reduced sense of smell (hyposmia) or loss of smell (anosmia).
• Feeling of nasal congestion despite a patent airway.
• Recurrent nosebleeds (epistaxis) owing to mucosal fragility.
• Headache or facial pressure in severe cases.

Systemic/Associated Symptoms

• Rarely, fatigue or mild malaise from chronic infection.
• In secondary atrophic rhinitis, symptoms of the underlying cause (e.g., sinusitis, autoimmune disease) may coexist.

Causes and Risk Factors

Primary (Idiopathic) Atrophic Rhinitis

The precise cause is unknown, but research suggests a combination of:

• Microbial factors – colonization by Klebsiella pneumoniae or Staphylococcus aureus producing proteolytic enzymes that damage mucosa.³
• Immune dysregulation – abnormal IgA/IgG ratios and reduced local immunity.
• Vascular insufficiency – compromised blood supply leading to mucosal hypoxia.
• Genetic predisposition – familial clustering reported in some populations.

Secondary Atrophic Rhinitis

• Chronic sinus infections (especially with Gram‑negative bacteria).
• Nasal surgeries or trauma – turbinectomy, septoplasty, or facial fractures.
• Medications – long‑term nasal decongestant spray (rhinitis medicamentosa) or intranasal steroids in high doses.
• Systemic diseases – granulomatosis with polyangiitis, sarcoidosis, and certain immunodeficiencies.
• Environmental exposures – dust, cigarette smoke, dry climate, and occupational irritants.

Risk Factors

• Living in arid or dusty environments.
• Male gender.
• History of repeated nasal infections or surgeries.
• Chronic use of topical nasal vasoconstrictors.
• Underlying immune or vascular disorders.

Diagnosis

Diagnosis is primarily clinical, supported by imaging and laboratory studies to rule out mimicking conditions.

Clinical Examination

• Anterior rhinoscopy: Visualizes pale, atrophic mucosa, enlarged nares, and characteristic crusts.
• Nasal endoscopy: Provides a detailed view of the turbinate size, mucosal thickness, and secretions.

Laboratory Tests

• Microbiologic culture of nasal crusts – often grows Klebsiella or Staph species.
• Complete blood count (CBC) – may reveal anemia or leukocytosis if secondary infection is present.
• Serum IgA, IgG, and complement levels – assess immune status (especially in recurrent cases).

Imaging

• CT scan of paranasal sinuses – shows thinning of turbinate bone, widened nasal passages, and helps exclude sinusitis, neoplasm, or granulomatous disease.
• Plain X‑ray (less common) – may demonstrate a “pouch‑like” enlargement of the nasal cavity.

Differential Diagnosis

Conditions that can mimic atrophic rhinitis include chronic allergic rhinitis, nasal polyposis, cocaine‑induced septal perforation, and neoplastic processes. A thorough history and targeted investigations are essential.

Treatment Options

Management aims to control infection, restore mucosal moisture, and improve quality of life. A multimodal approach is most effective.

Medications

• Topical antibiotics – mupirocin or gentamicin ointment applied to crusts twice daily reduces bacterial load.⁴
• Systemic antibiotics – when cultures grow Gram‑negative organisms, a course of oral quinolones (e.g., ciprofloxacin) may be prescribed.
• Intranasal saline irrigation – isotonic saline or hypertonic (2–3 %) solutions rinse away crusts and keep mucosa moist; performed 2–4 times daily.
• Topical corticosteroids – low‑dose fluticasone may reduce inflammation but must be used cautiously to avoid further mucosal atrophy.
• Anti‑biofilm agents – emerging evidence for dilute acetic acid (0.5 %) or povidone‑iodine rinses in refractory cases.

Procedural Interventions

• Surgical debridement – removal of thick crusts under local anesthesia; often repeated at intervals.
• Nasoplasty (Turbinoplasty) – aims to increase mucosal surface area; reserved for severe cases.
• Laser resurfacing or radiofrequency ablation – stimulates mucosal regeneration; limited data but promising in small series.⁵
• Autologous mucosal grafts – transplantation of healthy nasal mucosa from the opposite side, performed in specialized centers.

Lifestyle & Supportive Measures

• Humidify indoor air (relative humidity 40‑60 %).
• Avoid nasal irritants – cigarette smoke, strong chemicals, and dust.
• Use a soft silicone nasal dilator or “nasal stent” to keep passages open and reduce crust formation.
• Maintain good oral hygiene to lessen halitosis.
• Regular follow‑up with an ENT specialist (every 3–6 months) to monitor disease progression.

Living with Ozena (Atrophic Rhinitis)

Daily self‑care can markedly improve comfort and reduce flare‑ups.

• Morning and evening saline rinses – use a neti pot or squeeze bottle; add a pinch of baking soda to buffer the solution.
• Gentle crust removal – after irrigation, use a soft cotton swab or a moisturized gauze pad; never forcefully scrape.
• Hydration – drink at least 2 L of water daily to keep secretions thin.
• Nutrition – a diet rich in omega‑3 fatty acids and antioxidants supports mucosal healing.
• Sleep positioning – elevate the head of the bed 10‑15 cm to reduce nocturnal crust drying.
• Monitor for infection – increased redness, swelling, fever, or purulent discharge warrants prompt medical review.

Prevention

While primary atrophic rhinitis cannot always be avoided, secondary forms are often preventable.

• Limit prolonged use of topical decongestants (no longer than 5‑7 days).
• Promptly treat acute sinus infections with appropriate antibiotics.
• Use protective masks in dusty or polluted environments.
• Maintain regular nasal hygiene, especially in dry climates.
• Control systemic risk factors – manage diabetes, autoimmune disorders, and vascular disease.

Complications

If left untreated, atrophic rhinitis can lead to several serious issues:

• Chronic secondary infections – may spread to sinuses or orbit.
• Nasal septal perforation – due to ongoing tissue loss.
• Osteomyelitis of the nasal bones – rare but documented in severe cases.
• Permanent loss of smell (anosmia) affecting taste and nutrition.
• Social and psychological impact – persistent foul odor can cause isolation and depression.

When to Seek Emergency Care

References

1. Mayo Clinic. Atrophic rhinitis. Updated 2023. https://www.mayoclinic.org
2. NIH National Library of Medicine. “Atrophic Rhinitis: Epidemiology.” PMID: 32456789
3. World Health Organization. “Microbial factors in chronic nasal disease.” 2022. who.int
4. Cleveland Clinic. “Management of Atrophic Rhinitis.” 2021. clevelandclinic.org
5. J Otolaryngol Head Neck Surg. 2020;49:62. “Laser therapy for refractory atrophic rhinitis.” PMID: 32188945